Dariohealth Corp Stock Analysis

DRIO Stock  USD 0.72  0.05  7.46%   
DarioHealth Corp is undervalued with Real Value of 2.49 and Target Price of 7.82. The main objective of DarioHealth Corp stock analysis is to determine its intrinsic value, which is an estimate of what DarioHealth Corp is worth, separate from its market price. There are two main types of DarioHealth Corp's stock analysis: fundamental analysis and technical analysis.
The DarioHealth Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. DarioHealth Corp is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. DarioHealth Stock trading window is adjusted to America/New York timezone.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.

DarioHealth Stock Analysis Notes

About 18.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. DarioHealth Corp recorded a loss per share of 0.93. The entity last dividend was issued on the 18th of November 2019. The firm had 1:20 split on the 18th of November 2019. DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people. To learn more about DarioHealth Corp call Erez Raphael at 972 477 0637 7 or check out https://www.dariohealth.com.

DarioHealth Corp Investment Alerts

DarioHealth Corp generated a negative expected return over the last 90 days
DarioHealth Corp has high historical volatility and very poor performance
DarioHealth Corp has some characteristics of a very speculative penny stock
DarioHealth Corp has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 20.35 M. Net Loss for the year was (59.43 M) with profit before overhead, payroll, taxes, and interest of 14.01 M.
DarioHealth Corp currently holds about 67.95 M in cash with (30.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
DarioHealth Corp has a poor financial position based on the latest SEC disclosures
Roughly 18.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Dario Signs Four New Employer Contracts Across Full Product Suite

DarioHealth Corp Upcoming and Recent Events

Earnings reports are used by DarioHealth Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

DarioHealth Largest EPS Surprises

Earnings surprises can significantly impact DarioHealth Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-11
2023-03-31-0.5-0.450.0510 
2023-08-10
2023-06-30-0.52-0.58-0.0611 
2022-11-14
2022-09-30-0.76-0.640.1215 
View All Earnings Estimates

DarioHealth Corp Thematic Classifications

In addition to having DarioHealth Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Medical Equipment Idea
Medical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

DarioHealth Stock Institutional Investors

Shares
Renaissance Technologies Corp2024-09-30
87.7 K
Ubs Group Ag2024-06-30
77.3 K
State Street Corp2024-06-30
75 K
Northern Trust Corp2024-09-30
69.5 K
Citadel Advisors Llc2024-09-30
66.4 K
Susquehanna International Group, Llp2024-06-30
38.4 K
Xtx Topco Ltd2024-09-30
29.5 K
Clarity Capital Partners Llc2024-09-30
28.2 K
Bank Of Montreal2024-06-30
25.5 K
Nantahala Capital Management, Llc2024-09-30
2.5 M
Appian Way Asset Management2024-09-30
1.4 M
Note, although DarioHealth Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

DarioHealth Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.56 M.

DarioHealth Profitablity

The company has Profit Margin (PM) of (2.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.62) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.62.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.20)(1.26)
Return On Capital Employed(0.67)(0.70)
Return On Assets(0.62)(0.65)
Return On Equity(1.02)(0.97)

Management Efficiency

DarioHealth Corp has return on total asset (ROA) of (0.3474) % which means that it has lost $0.3474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7491) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -1.26. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, DarioHealth Corp's Intangibles To Total Assets are very stable compared to the past year. As of the 29th of November 2024, Debt To Assets is likely to grow to 0.31, while Other Current Assets are likely to drop about 1 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.05  2.15 
Tangible Book Value Per Share 0.39  0.41 
Enterprise Value Over EBITDA(0.76)(0.80)
Price Book Value Ratio 0.84  0.71 
Enterprise Value Multiple(0.76)(0.80)
Price Fair Value 0.84  0.71 
Enterprise Value41.5 M27.6 M
The operational strategies employed by DarioHealth Corp management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin
(1.62)
Profit Margin
(2.06)
Beta
1.511
Return On Assets
(0.35)
Return On Equity
(0.75)

Technical Drivers

As of the 29th of November, DarioHealth Corp shows the Standard Deviation of 5.13, mean deviation of 4.0, and Variance of 26.35. DarioHealth Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

DarioHealth Corp Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. DarioHealth Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for DarioHealth Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

DarioHealth Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DarioHealth Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on DarioHealth Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DarioHealth Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Nelson Steven Charles over two weeks ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9092 subject to Rule 16b-3
 
Nelson Steven Charles over three weeks ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3
 
Nelson Steven Charles over three weeks ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8442 subject to Rule 16b-3
 
Nelson Steven Charles over two months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3
 
Nelson Steven Charles over two months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8 subject to Rule 16b-3
 
Nelson Steven Charles over two months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8401 subject to Rule 16b-3
 
Nelson Steven Charles over two months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8182 subject to Rule 16b-3
 
Erez Raphael over three months ago
Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.88 subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9499 subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.945 subject to Rule 16b-3
 
Erez Raphael over three months ago
Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.95 subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9369 subject to Rule 16b-3

DarioHealth Corp Outstanding Bonds

DarioHealth Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DarioHealth Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DarioHealth bonds can be classified according to their maturity, which is the date when DarioHealth Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

DarioHealth Corp Predictive Daily Indicators

DarioHealth Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DarioHealth Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

DarioHealth Corp Forecast Models

DarioHealth Corp's time-series forecasting models are one of many DarioHealth Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DarioHealth Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About DarioHealth Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how DarioHealth Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DarioHealth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DarioHealth Corp. By using and applying DarioHealth Stock analysis, traders can create a robust methodology for identifying DarioHealth entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(2.92)(3.06)
Operating Profit Margin(2.76)(2.90)
Net Loss(2.92)(3.07)
Gross Profit Margin 0.29  0.31 

Current DarioHealth Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. DarioHealth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. DarioHealth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.82Strong Buy3Odds
DarioHealth Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most DarioHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand DarioHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of DarioHealth Corp, talking to its executives and customers, or listening to DarioHealth conference calls.
DarioHealth Analyst Advice Details

DarioHealth Stock Analysis Indicators

DarioHealth Corp stock analysis indicators help investors evaluate how DarioHealth Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading DarioHealth Corp shares will generate the highest return on investment. By understating and applying DarioHealth Corp stock analysis, traders can identify DarioHealth Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow49.5 M
Long Term Debt24.6 M
Common Stock Shares Outstanding28.4 M
Total Stockholder Equity58.1 M
Tax Provision3000.00
Property Plant And Equipment Net1.9 M
Cash And Short Term Investments36.8 M
Cash36.8 M
Accounts Payable1.1 M
Net Debt-7.3 M
50 Day M A0.9412
Total Current Liabilities12.5 M
Other Operating Expenses76.5 M
Non Current Assets Total49.3 M
Non Currrent Assets Other387 K
Stock Based Compensation19.7 M
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.93)
Revenue Per Share
0.631
Quarterly Revenue Growth
1.11
Return On Assets
(0.35)
Return On Equity
(0.75)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.